SCHEMBL22601477

SCHEMBL22601477

CCOC(=O)c1cnc(SC)nc1N1CCOCC1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.80
KMT2A Q03164 1/20 0.80
ALOX15 P16050 1/20 0.61
PDE4B Q07343 5/20 0.57
PDE4A P27815 2/20 0.55
PDE4C Q08493 2/20 0.55
PDE4D Q08499 2/20 0.55
PDE11A Q9HCR9 2/20 0.55
PDE3B Q13370 1/20 0.55
ALDH1A1 P00352 4/20 0.54
LMNA P02545 1/20 0.54
KDM4E B2RXH2 2/20 0.53
MAPT P10636 2/20 0.52
POLB P06746 2/20 0.51
TP53 P04637 2/20 0.51
TDP1 Q9NUW8 1/20 0.50
PKM P14618 1/20 0.48
USP2 O75604 1/20 0.48
MAPK1 P28482 1/20 0.48
RECQL P46063 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20987614 0.87 MEN1 (0.74) MEN1KMT2AALOX15PDE4BPDE4A
SCHEMBL6648802 0.85 MEN1 (0.79) MEN1KMT2AALOX15ALDH1A1LMNA
SCHEMBL18395699 0.83 ALOX15 (0.64) MEN1KMT2AALOX15ALDH1A1LMNA
SCHEMBL22440417 0.83 MEN1 (0.76) MEN1KMT2AALOX15PDE4BALDH1A1
SCHEMBL22440409 0.83 PDE4B (0.64) MEN1KMT2AALOX15PDE4BPDE4A
SCHEMBL30378685 0.81 MEN1 (0.72) MEN1KMT2AALOX15PDE4BPDE4A
SCHEMBL573492 0.81 ALOX15 (0.61) MEN1KMT2AALOX15PDE4BPDE4A
SCHEMBL20098255 0.81 ALOX15 (0.60) MEN1KMT2AALOX15PDE4BPDE4A
SCHEMBL20098549 0.81 ALOX15 (0.60) MEN1KMT2AALOX15ALDH1A1LMNA
SCHEMBL6696056 0.80 SYK (0.68) MEN1KMT2AALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200339534-A1 BENZAMIDE DERIVATIVE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING INFLAMMATORY DISEASE CONTAINING SAME AS ACTIVE INGREDIENT SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2020-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200339534-A1 BENZAMIDE DERIVATIVE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING INFLAMMATORY DISEASE CONTAINING SAME AS ACTIVE INGREDIENT IL4, IL5, IL15 MEN1 4483/4885KMT2A 1976/4885ALOX15 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.